Smoking cessation.
Conditions
Interventions
Intervention 1: Intervention group: Patients taking tabex tablets of Sopharma Bulgaria in the form of protocol approved by the company.The Cytisine protocol is as follows:Days 1 to 3: 6 tablets a day,
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: At least 18 years of age Daily smokers Motivated to quit
Exclusion criteria
Exclusion criteria: Pregnant or breast-feeding women Enrolled in another cessation program or study Systolic blood pressure above 150 mm Hg Diastolic blood pressure above 100 mm Hg Cardiovascular event in the 2 weeks before study enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Smoking cessation. Timepoint: 1 week and at1, 2 and 6 months after quit day. Method of measurement: 1)mood and physical symptoms scale (MPSS)The AUDIT alcohol 2)consumption questions (AUDIT-C)Confirmatory factor analyses and 3)reliability of the modified cigarette evaluation questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: 1 week and at1, 2 and 6 months after quit day. Method of measurement: 1)Mood and physical symptoms scale (MPSS) 2)The AUDIT alcoholconsumption questions (AUDIT-C). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZeynab Gholamzadeh Sani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed